296 related articles for article (PubMed ID: 24269662)
1. Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():50-8. PubMed ID: 24269662
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 is a human microsomal vitamin D 25-hydroxylase.
Gupta RP; Hollis BW; Patel SB; Patrick KS; Bell NH
J Bone Miner Res; 2004 Apr; 19(4):680-8. PubMed ID: 15005856
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism.
Deb S; Pandey M; Adomat H; Guns ES
Drug Metab Dispos; 2012 May; 40(5):907-18. PubMed ID: 22301272
[TBL] [Abstract][Full Text] [Related]
5. Hydroxylation of 20-hydroxyvitamin D3 by human CYP3A4.
Cheng CY; Slominski AT; Tuckey RC
J Steroid Biochem Mol Biol; 2016 May; 159():131-41. PubMed ID: 26970587
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D
Maeng HJ; Doan TNK; Yoon IS
Drug Dev Res; 2019 May; 80(3):333-342. PubMed ID: 30537097
[TBL] [Abstract][Full Text] [Related]
8. The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism.
Uga M; Kaneko I; Shiozaki Y; Koike M; Tsugawa N; Jurutka PW; Miyamoto KI; Segawa H
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927120
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of 1α,2α,25-trihydroxyvitamin D3: active metabolite of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP3A4.
Takano M; Ohya S; Yasuda K; Nishikawa M; Takeuchi A; Sawada D; Sakaki T; Kittaka A
Chem Pharm Bull (Tokyo); 2014; 62(2):182-4. PubMed ID: 24492588
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
[TBL] [Abstract][Full Text] [Related]
13. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia.
Xu Y; Hashizume T; Shuhart MC; Davis CL; Nelson WL; Sakaki T; Kalhorn TF; Watkins PB; Schuetz EG; Thummel KE
Mol Pharmacol; 2006 Jan; 69(1):56-65. PubMed ID: 16207822
[TBL] [Abstract][Full Text] [Related]
16. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)
Lee SJ; Joo SA; Kim H; Lee Y; Chung SJ; Chae YJ; Maeng HJ
Eur J Pharm Sci; 2023 Apr; 183():106396. PubMed ID: 36736464
[TBL] [Abstract][Full Text] [Related]
18. The serum vitamin D metabolome: What we know and what is still to discover.
Tuckey RC; Cheng CYS; Slominski AT
J Steroid Biochem Mol Biol; 2019 Feb; 186():4-21. PubMed ID: 30205156
[TBL] [Abstract][Full Text] [Related]
19. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents.
Lehmann B; Rudolph T; Pietzsch J; Meurer M
Exp Dermatol; 2000 Apr; 9(2):97-103. PubMed ID: 10772383
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.
Wang Z; Lin YS; Dickmann LJ; Poulton EJ; Eaton DL; Lampe JW; Shen DD; Davis CL; Shuhart MC; Thummel KE
J Bone Miner Res; 2013 May; 28(5):1101-16. PubMed ID: 23212742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]